Twinlab Consolidated Holdings, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Twinlab Consolidated Holdings, Inc. - overview
Location
Boca Raton, FL, US
Primary Industry
Food
About
Twinlab Consolidated Holdings, Inc. is a health and wellness company specializing in dietary supplements that promote enhanced health and vitality, offering a variety of products tailored to diverse consumer needs. Twinlab Consolidated Holdings, Inc. is focused on the production of health supplements.
Founded by Teguh Handoko, the company has its headquarters in Boca Raton, US. It received its most recent funding round in November 2014, when Assurance Mezzanine invested in the company. The financial details of this deal were not disclosed. Twinlab Consolidated Holdings, Inc.
operates primarily in the health and wellness sector, focusing on dietary supplements designed to enhance overall health and vitality. The company's flagship brand, Twinlab, has been a cornerstone of its product portfolio for over 50 years, offering a range of vitamins, minerals, and specialty supplements that cater to diverse health needs. Additional brands under the Twinlab umbrella include Reserveage Beauty, which specializes in beauty supplements enriched with ingredients like Resveratrol. These products support various consumer health objectives, including improved cognitive function, enhanced skin health, and overall wellness.
The company serves a broad client base, including individual consumers and retail partners, and is distributed across multiple geographical markets with significant presence in North America and expanding outreach to Europe and Asia. Twinlab Consolidated Holdings, Inc. generated revenue of USD 13. 62 mn in the most recent year, 2023, with an EBITDA of USD -731,000.
The company utilizes a multi-faceted distribution strategy that includes both direct-to-consumer sales and partnerships with retailers and wholesalers, ensuring a steady revenue stream through competitive pricing and extensive market partnerships. Twinlab Consolidated Holdings, Inc. plans to expand its product offerings and enhance its market presence. The company is in the process of designing new products, although specific launch dates have not been disclosed.
Additionally, Twinlab aims to expand into European and Asian markets by the end of 2025. The funding received in November 2014 will support these initiatives, assisting in product development and market penetration efforts.
Current Investors
Assurance Mezzanine
Primary Industry
Food
Sub Industries
Consumer Products, Health Foods & Nutritional Supplements
Website
www.tchhome.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Twinlab Consolidated Holdings, Inc. - timeline of key events
Twinlab Consolidated Holdings, Inc. - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 61,426,000 | 81,672,000 | 86,323,000 | 85,501,000 | 73,291,000 | 73,460,000 | 66,349,000 | - | - | - |
| % Revenue Growth (YoY) | - | 33.0% | 5.7% | (1.0%) | (14.3%) | 0.2% | (9.7%) | - | - | - |
| EBITDA (USD) | (10,727,000) | (10,346,000) | (5,879,000) | (15,536,000) | (8,858,000) | (34,927,000) | (2,522,000) | - | - | - |
| Operating Income (USD) | (12,152,000) | (13,932,000) | (12,359,000) | (21,125,000) | (13,990,000) | (38,767,000) | (5,408,000) | - | - | - |
| Operating Margin | (19.8%) | (17.1%) | (14.3%) | (24.7%) | (19.1%) | (52.8%) | (8.2%) | - | - | - |
| % EBITDA Margin | (17.5%) | (12.7%) | (6.8%) | (18.2%) | (12.1%) | (47.5%) | (3.8%) | - | - | - |
| NET Income (USD) | (21,130,000) | (36,410,000) | (684,000) | (29,491,000) | (20,409,000) | (44,501,000) | (14,389,000) | - | - | - |
| % Net Margin | (34.4%) | (44.6%) | (0.8%) | (34.5%) | (27.8%) | (60.6%) | (21.7%) | - | - | - |
Twinlab Consolidated Holdings, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Twinlab Consolidated Holdings, Inc. | - |
Displaying 1 - 1 of 1
Twinlab Consolidated Holdings, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.